e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Clinical physiology and respiratory muscles
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled vilanterol trifenatate/fluticasone furoate increases maximum diaphragm contraction in severe COPD
J. Jagers, M. Ji, M. Johnson, E. Wilde, P. Easton (Calgary, Canada; Uxbridge, United Kingdom)
Source:
International Congress 2014 – Clinical physiology and respiratory muscles
Session:
Clinical physiology and respiratory muscles
Session type:
Poster Discussion
Number:
3538
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Jagers, M. Ji, M. Johnson, E. Wilde, P. Easton (Calgary, Canada; Uxbridge, United Kingdom). Inhaled vilanterol trifenatate/fluticasone furoate increases maximum diaphragm contraction in severe COPD. Eur Respir J 2014; 44: Suppl. 58, 3538
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD
Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases
Year: 2014
Inhaled vilanterol trifenatate/fluticasone furoate (VFF) improves respiratory muscle function and walking performance in severe COPD without change in pulmonary function
Source: International Congress 2017 – Management of COPD
Year: 2017
Effect of vilanterol trifenatate/fluticasone furoate on parasternal raw EMG in severe COPD: Turns analysis
Source: International Congress 2014 – Clinical physiology and respiratory muscles
Year: 2014
Inhaled beta-agonist does not modify sympathetic activity in patients with COPD
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Influence of reduced airway patency and respiratory muscle strength on autonomic cardiac modulation in COPD patients
Source: International Congress 2016 – Quality and quantity in lung function
Year: 2016
The functional state of the diaphragm in COPD patients with hypoxemia
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Association between dynamic hyperinflation and emphysema distribution in COPD patients
Source: International Congress 2014 – Mechanisms of exercise limitation in disease
Year: 2014
Respiratory impedance by forced oscillation of multi-frequencies technique in asthma with and without airflow obstruction and COPD with and without emphysema
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
The relation between hyperinflation and daily activity in COPD patients
Source: International Congress 2014 – Clinical exercise physiology in health and COPD
Year: 2014
Morpho-mathematic biomarkers of bronchodilators' response in COPD patients during resting spontaneous breathing
Source: International Congress 2014 – Clinical physiology and respiratory muscles
Year: 2014
Effects of inhaled furosemide on exercise capacity and on dyspnea in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
The effects of salmeterol on respiratory muscle activity and ventilatory mechanics in poorly reversible COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 209s
Year: 2003
Small airway dysfunction is associated to the excessive bronchoconstriction in asthma
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
Exertional dyspnoea, dynamic hyperinflation and respiratory muscle function in idiopathic pulmonary arterial hypertension (PAHi)
Source: International Congress 2014 – Mechanisms of exercise limitation in health and disease
Year: 2014
Neural respiratory drive (NRD) measured by parasternal electromyography predicts clinical deterioration and early readmission in patients with acute exacerbation of COPD (AECOPD)
Source: International Congress 2014 – Respiratory pathophysiology: mechanisms of alteration of lung, respiratory and peripheral muscle function
Year: 2014
Improvement in airflow obstruction with inhaled bronchodilators influences the pattern of abdominal muscle recruitment during exercise in COPD
Source: Annual Congress 2010 - Thoracic dynamics and dyspnoea on exercise
Year: 2010
Inspiratory capacity manoeuvres may underestimate dynamic hyperinflation in patients with COPD; the explanation for apparent non-inflators
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016
Neuromuscular dissociation of the diaphragm is more pronounced during treadmill exercise compared with cycle exercise in obese COPD patients
Source: International Congress 2014 – Clinical physiology and respiratory muscles
Year: 2014
Effect of short-acting bronchodilators (BDs) on the severity of respiratory muscle (RM) strength in COPD patients (pts)
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Effects of inspiratory muscle training and respiratory exercise at muscle function, thoracoabdominal mobility and dyspnea in patients with COPD
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment methods in COPD and asthma
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept